NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis

RecruitingPhase 2

Sponsor: Pakistan Institute of Medical Sciences

Conditions: Acute Bronchiolitis

Interventions: Montelukast, Placebo

Countries: Pakistan

This study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms

Eligibility overview

Sex: ALL

Age: 4 Weeks to 2 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

* Age 4 weeks to 2 years
* Both genders
* Duration of respiratory symptoms less than 4 days
* Clinical diagnosis of acute bronchiolitis according to the operational definition provided in the study protocol

Exclusion Criteria

* History of asthma
* Previous hospital admissions for respiratory illness
* Use of asthma medications
* Congenital heart disease
* Bronchopulmonary dysplasia
* Immunodeficiency
* Immunosuppression
* Radiological evidence of pneumonia, including infiltrates or patches on chest X-ray

Locations (1)

Islamabad, Federal, Pakistan